APA (7th ed.) Citation

Schuler, M., Wu, Y., Hirsh, V., O’Byrne, K., Yamamoto, N., Mok, T., . . . Yang, J. C. (2016). First-Line Afatinib versus Chemotherapy in Patients with Non–Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain Metastases. Journal of thoracic oncology, 11(3), 380-390. https://doi.org/10.1016/j.jtho.2015.11.014

Chicago Style (17th ed.) Citation

Schuler, Martin, et al. "First-Line Afatinib Versus Chemotherapy in Patients with Non–Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain Metastases." Journal of Thoracic Oncology 11, no. 3 (2016): 380-390. https://doi.org/10.1016/j.jtho.2015.11.014.

MLA (9th ed.) Citation

Schuler, Martin, et al. "First-Line Afatinib Versus Chemotherapy in Patients with Non–Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain Metastases." Journal of Thoracic Oncology, vol. 11, no. 3, 2016, pp. 380-390, https://doi.org/10.1016/j.jtho.2015.11.014.